Page last updated: 2024-11-05

thalidomide and Mycoses

thalidomide has been researched along with Mycoses in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Mycoses: Diseases caused by FUNGI.

Research Excerpts

ExcerptRelevanceReference
" Others report on the use of thalidomide or IL-10 for curtailing or suppressing tumor necrosis factor alpha in coincident HIV and tuberculosis patients."3.69Or is it the host, sir? ( Mascolini, M, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passeron, T1
Mascolini, M1

Reviews

1 review available for thalidomide and Mycoses

ArticleYear
[What's new in dermatological research?].
    Annales de dermatologie et de venereologie, 2010, Volume: 137 Suppl 4

    Topics: Biomedical Research; Dermatitis, Atopic; Dermatology; Herpesviridae Infections; HIV Infections; Huma

2010

Other Studies

1 other study available for thalidomide and Mycoses

ArticleYear
Or is it the host, sir?
    Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:9

    Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Anti-Infective Agents; CD8-Positive T

1996